Our team previously demonstrated that CCR2 content in AAAs, as demonstrated by positron emission tomography (PET)/computed tomography (CT) imaging in a preclinical rodent model, highly correlates with the incidence of AAA expansion and the risk of rupture13,14. Here, CCR2 is linked to achalasia-alacrima syndrome.